GL1X · GenesisL1 explorer

Research workbench

Crystal structure of DR15 presenting the RQ13 peptide

Analyse Crystal structure of DR15 presenting the RQ13 peptide in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6CPO
Type
protein
Length
762 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P01903, D7RIH9, P04591
Ligands
NAG, PO4

Structure

x-ray diffraction · 5 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein178—P01903
B—protein189—D7RIH9
C, F—protein13—P04591
D—protein179—P01903
E—protein190—D7RIH9

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains A, B, D
  • PO4 · Phosphate ion · ion · 2 copies · chains B, D, E
  • PGE · Triethylene glycol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6CPO · Crystal structure of DR15 presenting the RQ13 peptide · the same entry in another collection · chain B against B, TM-score 1.00
  • P01903 · AlphaFold monomer V2.0 prediction for HLA class II histocompatibility antigen, dr alpha… · a predicted model of the same protein · chain D against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.